Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 8/20 | 0.50 |
| ▸ | NOX1 | Q9Y5S8 | 9/20 | 0.47 |
| ▸ | GAA | P10253 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | HTR2C | P28335 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29600380 | 1.00 | SNCA (0.50) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL29625245 | 1.00 | SNCA (0.50) | SNCANOX1GAAMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL12470954 | 0.98 | SNCA (0.48) | SNCANOX1GAAMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL31175976 | 0.98 | SNCA (0.48) | SNCANOX1GAAMAPTMEN1 | |
| Iodide SCHEMBL1206518 | 0.98 | SNCA (0.48) | SNCANOX1GAAMAPTMEN1 | |
| Iodide SCHEMBL29850697 | 0.98 | SNCA (0.48) | SNCANOX1GAAMAPTMEN1 | |
| Iodide SCHEMBL28955143 | 0.98 | SNCA (0.48) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL28571001 | 0.92 | NOX1 (0.48) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL30867071 | 0.92 | NOX1 (0.48) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL237910 | 0.90 | NOX1 (0.65) | SNCANOX1GAAMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 543 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188379-A1 | FUSED-RING POLYCYCLIC AMINE FUNCTIONALIZED OLEFINIC POLYMERS FOR LUBRICATING OIL COMPOSITIONS | INFINEUM INTERNATIONAL LIMITED (GB) | 2025-06-12 | — | — | US | claimed |
| US-20190151329-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (SG) | 2019-05-23 | — | — | US | claimed |
| US-10188658-B2 | Therapeutic use of diaminophenothiazines | WISTA LABORATORIES LTD. (SG) | 2019-01-29 | — | — | US | claimed |
| EP-2954932-B1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | WISTA LAB LTD (SG) | 2018-09-19 | — | — | EP | claimed |
| US-20170050044-A1 | Integumentary System Therapy | LEBOVITZ RUSSELL M (US) | 2017-02-23 | — | — | US | claimed |
| EP-2978856-B1 | SELECTIVE CHROMOGENIC MEDIUM | Szegedi Tudományegyetem (HU) | 2017-02-22 | — | — | EP | claimed |
| WO-2017015174-A1 | INTEGUMENTARY SYSTEM THERAPY | LEBOVITZ RUSSELL M (US) | 2017-01-26 | — | — | WO | claimed |
| CN-106353307-A | Small-size color change indication device | 深圳九星印刷包装集团有限公司 | 2017-01-25 | — | — | CN | claimed |
| US-20160237048-A1 | PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2016-08-18 | — | — | US | claimed |
| US-20160051559-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2016-02-25 | — | — | US | claimed |
| US-20100280975-A1 | SYSTEMS FOR CLINICAL TRIALS | WISTA LABORATORIES LTD. | 2010-11-04 | — | — | US | claimed |
| EP-2227766-A2 | SYSTEMS FOR CLINICAL TRIALS | Wista Laboratories Ltd. (SG) | 2010-09-15 | — | — | EP | claimed |
| EP-2205245-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | Wista Laboratories Ltd. (SG) | 2010-07-14 | — | — | EP | claimed |
| WO-2009060191-A2 | SYSTEMS FOR CLINICAL TRIALS | WISTA LABORATORIES LTD. (GB) | 2009-05-14 | — | — | WO | claimed |
| WO-2009044127-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (GB) | 2009-04-09 | — | — | WO | claimed |
| WO-2009007376-A1 | PHARMACEUTICAL COMPOSITIONS FOR PERORAL ADMINISTRATION OF PHENOTHIAZINE DYESTUFFS | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2009-01-15 | — | — | WO | claimed |
| WO-2007144048-A2 | PRESENTATION FORM FOR THE ORAL ADMINISTRATION OF PHENOTHIAZINE DYES, ITS PRODUCTION AND USE | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO. KG (AT) | 2007-12-21 | — | — | WO | claimed |
| CN-101022852-A | Acousto-optic dynamic therapy for dental applications | ONDINE INT LTD (BB) | 2007-08-22 | — | — | CN | claimed |
| US-5486582-A | Polymer scale preventive process using a coating of chitosan salt and phenothiazine | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1996-01-23 | — | — | US | claimed |
| EP-0330456-B1 | Preparation of silicon-containing polyimide precursor and cured polyimides obtained therefrom | CHISSO CORP (JP) | 1994-09-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050044-A1 | Integumentary System Therapy | OTC, SUCLG1, TYR | SNCA 3988/4885NOX1 428/4885GAA 340/4885 |
| US-20160051559-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | SNCA 673/4885NOX1 187/4885GAA 2333/4885 |
| US-20160237048-A1 | PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE | QDPR, SLC35A1, SLC6A7 | SNCA 427/4885NOX1 2683/4885GAA 102/4885 |
| US-10188658-B2 | Therapeutic use of diaminophenothiazines | QDPR, DDO, HNMT | SNCA 430/4885NOX1 2397/4885GAA 228/4885 |
| US-20190151329-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | QDPR, DDO, HNMT | SNCA 398/4885NOX1 2264/4885GAA 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.